Login to Your Account

Clinic Roundup

Tuesday, March 29, 2011
The FDA has cleared an investigational new drug request from Evolva Holding SA, of Reinach, Switzerland, paving the way for a human trial of EV-077 to treat influenza. In preclinical testing, the candidate showed potential as prophylaxis and treatment of various viral infections, according to the company.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription